v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2024   40,724,936      
Balance at beginning of period at Dec. 31, 2024 $ (1,188) $ 40 $ 135,522 $ 135 $ (136,885)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   145,959      
Issuance of common stock upon exercise of stock options 148   148    
Issuance of common stock for settlement of Restricted Stock Units (RSUs) (in shares)   532,399      
Issuance of common stock for settlement of Restricted Stock Units (RSUs) 0 $ 1 (1)    
Issuance of common stock in connection with business combination 0        
Stock-based compensation expense 4,346   4,346    
Unrealized losses on available-for-sale securities, net of tax (6)     (6)  
Net loss (8,121)       (8,121)
Balance at end of period (in shares) at Mar. 31, 2025   41,403,294      
Balance at end of period at Mar. 31, 2025 $ (4,821) $ 41 140,015 129 (145,006)
Balance at beginning of period (in shares) at Dec. 31, 2025 44,268,816 44,268,816      
Balance at beginning of period at Dec. 31, 2025 $ (14,632) $ 44 156,776 179 (171,631)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   75,374      
Issuance of common stock upon exercise of stock options 349   349    
Issuance of common stock for settlement of Restricted Stock Units (RSUs) (in shares)   507,802      
Issuance of common stock for settlement of Restricted Stock Units (RSUs) 0 $ 1 (1)    
Issuance of common stock in connection with business combination (in shares)   1,096,280      
Issuance of common stock in connection with business combination 19,016 $ 1 19,015    
Issuance of common stock under the at-the-market agreement, net of commissions and offering costs (in shares)   69,636      
Issuance of common stock under the at-the-market agreement, net of commissions and offering costs 521   521    
Stock-based compensation expense 5,354   5,354    
Unrealized losses on available-for-sale securities, net of tax (58)     (58)  
Net loss $ (7,959)       (7,959)
Balance at end of period (in shares) at Mar. 31, 2026 46,017,908 46,017,908      
Balance at end of period at Mar. 31, 2026 $ 2,591 $ 46 $ 182,014 $ 121 $ (179,590)